Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    STARTRADER expands AI offering with 31 New US Share & ETF CFDs in Semiconductors, Optical Networking & Nuclear

    July 31, 2026

    Oman Deputy IT Minister Applauds Kingsoft Office’s AI Strategy

    July 31, 2026

    Esports Foundation and adidas Announce Landmark Partnership to Outfit Every Team at the Inaugural Esports Nations Cup

    July 30, 2026
    GCC DigestGCC Digest
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    GCC DigestGCC Digest
    Home » CGTN: China achieves ‘major, decisive’ victory in COVID-19 response: CPC leadership
    PR Newswire

    CGTN: China achieves ‘major, decisive’ victory in COVID-19 response: CPC leadership

    February 17, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    BEIJING, Feb. 17, 2023 /PRNewswire/ — Over the past three years, China has always been putting people’s lives and health first and adapting its COVID-19 response in light of the evolving situation, in efforts widely believed to have bought precious time for a smooth transition.

    The country has achieved a major and decisive victory in its COVID-19 prevention and control since November 2022, the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee said at a meeting on Thursday.

    It has been proved that the CPC’s major judgment, policy decision and strategy adjustment on COVID-19 are completely correct, said the meeting, which was presided over by Xi Jinping, general secretary of the CPC Central Committee.

    “The measures are effective. The people recognize them. And the achievement is huge,” it said.

    ‘A miracle’

    China has kept optimizing and adjusting its COVID-19 prevention and control measures since November 2022, with the focus on protecting people’s health and preventing severe cases.

    In a major shift in its response policies, the country started to manage COVID-19 with measures designed for combating Class B infectious diseases, instead of Class A infectious diseases since January 8, 2023.

    It was noted at Thursday’s meeting that China has realized a stable transition in its epidemic prevention and control stages in a relatively short period of time.

    With more than 200 million people having received medical treatment and nearly 800,000 seriously ill patients effectively cured since November, China has kept its COVID-19 death rates among the lowest in the world.

    “We have achieved a major and decisive victory in terms of epidemic prevention and control, creating a miracle in the history of human civilization in which a country with a huge population successfully emerges from a pandemic,” said the meeting.

    A new phase

    As China’s COVID-19 response enters a new phase, the country has been speeding up efforts to consolidate what has been achieved over the years in fighting the COVID-19 pandemic.

    It is important to strengthen epidemic monitoring capacity and improve regular early warning systems by establishing a sound surveillance and reporting mechanism, the meeting of the CPC leadership pointed out.

    It also called for efforts to make a scientific plan for next-stage vaccinations, in particular to increase the vaccination rates of the elderly.

    In face of the evolving COVID-19 strains, China has also stepped up the nation-wide promotion of booster shots. According to an updated action plan released by the State Council joint COVID-19 prevention and control mechanism, nine combinations of booster vaccines developed in different technical routes, including vaccines providing good cross immunity against the Omicron strain, are now available.

    Thursday’s meeting also underscored efforts to guarantee the production and supply of medical supplies, and improve their coordinated deployment mechanism.

    Efforts should also be made to advance scientific and technological breakthroughs in the health sector in a coordinated manner, and improve the level of life and health science and technology, the meeting concluded.

    https://news.cgtn.com/news/2023-02-16/Xi-chairs-CPC-leadership-meeting-on-latest-COVID-19-response-1htrVJOaUBW/index.html

    Cision View original content:https://www.prnewswire.co.uk/news-releases/cgtn-china-achieves-major-decisive-victory-in-covid-19-response-cpc-leadership-301749529.html

    Related Posts

    STARTRADER expands AI offering with 31 New US Share & ETF CFDs in Semiconductors, Optical Networking & Nuclear

    July 31, 2026

    Oman Deputy IT Minister Applauds Kingsoft Office’s AI Strategy

    July 31, 2026

    Esports Foundation and adidas Announce Landmark Partnership to Outfit Every Team at the Inaugural Esports Nations Cup

    July 30, 2026

    How Dubai Successfully Turned the Summer Break into a Platform for Prevention and Positive Youth Development

    July 30, 2026

    e& reports 11.6% increase in consolidated revenue to AED 38.1 billion in H1 2026

    July 30, 2026

    LG Launches New Award-Winning UltraGear™ evo 5K2K Gaming Monitor Line-up

    July 29, 2026
    News Bulletin

    Apple market cap reaches 4.94 trillion to top Nvidia

    July 29, 2026

    NEW YORK / RankWire.AI / – Consumer technology giant Apple reclaimed its position as the…

    Gold prices fall on strong dollar ahead of central bank meeting

    July 29, 2026

    World Capitals, United States / RankWire.AI / – Precious metal values declined during Tuesday trading…

    Porsche to cut 5000 more jobs under restructuring plan

    July 28, 2026

    Berlin, German / RankWire.AI / – German luxury sports car manufacturer Porsche announced an agreement…

    Senate crypto bill faces pushback over conflict of interest rules

    July 28, 2026

    WASHINGTON, / RankWire.AI / – Ethics watchdogs and legal experts called on Congress on Monday…

    © 2026 GCC Digest | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.